XOVR Among Its Peers
End-of-day Nov 20, 2026 · 1 ETFs by 1M
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| Total return | −6.7% | −11.8% | −14.6% | −11.5% | −11.8% | −9.2% | — | — | — | +25.6% |
| S&P 500 · VOO | −3.4% | −8.3% | −9.5% | −9.2% | +2.2% | +5.5% | +59.8% | +58.7% | +275.8% | — |
$68 of every $1,000 in XOVR is Nvidia
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | —SPV Exposure to SpaceX LP | — | 16.31% | $1,630.79 | 0 | $199.8M |
| 2 | NVDANvidia | Technology | 6.80% | $679.81 | 570K | $83.3M |
| 3 | GOOGLAlphabet | Communication Services | 5.26% | $526.26 | 236K | $64.5M |
| 4 | METAMETA Platforms | Communication Services | 4.51% | $450.59 | 93K | $55.2M |
| 5 | CARTMaplebear | Technology | 4.49% | $448.91 | 951K | $55.0M |
| 6 | UIUbiquiti | Technology | 4.48% | $447.63 | 83K | $54.8M |
| 7 | —Kalshi | — | 4.33% | $433.45 | 46K | $53.1M |
| 8 | SPCXSpace Exploration Technologies | Industrials | 3.80% | $380.48 | 337K | $46.6M |
| 9 | TOSTToast | Technology | 3.70% | $370.39 | 1.4M | $45.4M |
| 10 | APPAppLovin | Technology | 3.16% | $316.15 | 102K | $38.7M |
| 11 | GMEDGlobus Medical | Healthcare | 2.97% | $297.21 | 531K | $36.4M |
| 12 | NBIXNeurocrine Biosciences | Healthcare | 2.71% | $271.32 | 212K | $33.2M |
| 13 | EXELExelixis | Healthcare | 2.59% | $259.29 | 482K | $31.8M |
| 14 | ANETArista Networks | Technology | 2.49% | $249.26 | 161K | $30.5M |
| 15 | VEEVVeeva Systems | Technology | 2.47% | $247.31 | 115K | $30.3M |
XOVR has no close peers in our data yet: […]
No peers with a full year of prices to rank against yet.
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | NVDA | Nvidia | 6.80% |
| 2 | GOOGL | Alphabet | 5.26% |
| 3 | META | META Platforms | 4.51% |
| 4 | CART | Maplebear | 4.49% |
| 5 | UI | Ubiquiti | 4.48% |
| 6 | SPCX | Space Exploration Technologies | 3.80% |
| 7 | TOST | Toast | 3.70% |
| 8 | APP | AppLovin | 3.16% |
| 9 | GMED | Globus Medical | 2.97% |
| 10 | NBIX | Neurocrine Biosciences | 2.71% |
| Fund | Sharpe | Sortino | Volatility | Max DD | Beta | Fee / $10k |
|---|---|---|---|---|---|---|
| XOVR | −0.51 | −0.70 | 26.9% | −20.8% | 1.46 | $75 |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Dec 21, 2021 | Dec 28, 2021 | $8.73 |
| Dec 21, 2020 | Dec 23, 2020 | $1.65 |
| Dec 19, 2019 | Dec 23, 2019 | $0.0144 |
| Dec 18, 2018 | Dec 20, 2018 | $0.52 |
| Dec 22, 2017 | Dec 28, 2017 | $0.0127 |